M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently Than M1 Cells in Vitro
Journal of Immunology - United States
doi 10.4049/jimmunol.0713732
Full Text
Open PDFAbstract
Available in full text
Date
March 19, 2009
Authors
Publisher
The American Association of Immunologists